title: FHL2 interacts with both ADAM-17 and the cytoskeleton and regulates ADAM-17 localization and activity.
abstract: ADAM-17 is a metalloprotease-disintegrin responsible for the ectodomain shedding of several transmembrane proteins. Using the yeast two-hybrid system, we showed that ADAM-17 interacts with the Four and Half LIM domain 2 protein (FHL2), a LIM domain protein that is involved in multiple protein-protein interaction. We demonstrated that this interaction involved the amino-acid sequence of ADAM-17 from position 721 to739. In the cardiomyoblast cells H9C2, ADAM-17 and FHL2 colocalize with the actin-based cytoskeleton and we showed that FHL2 binds both ADAM-17 and the actin-based cytoskeleton. We found that mainly the mature form of ADAM-17 associates with the cytoskeleton, although the maturation of ADAM-17 by furin is not necessary for its binding to the cytoskeleton. Interestingly, less ADAM-17 was detected at the surface of wild-type mouse macrophages compared to FHL2 deficient macrophages. However, wild-type cells have a higher ability to release ADAM-17 substrates under PMA stimulation. Altogether, these results demonstrate a physical and functional interaction between ADAM-17 and FHL2 that implies that FHL2 has a role in the regulation of ADAM-17.
authors.affiliation: Inserm, U626, Marseilles, France; Université de la Méditerranée, Faculté de Médecine, Marseilles, Cedex 5, France.
authors.forename: Matthias
authors.initials: M
authors.lastname: Canault
authors.forename: Edwige
authors.initials: E
authors.lastname: Tellier
authors.forename: Bernadette
authors.initials: B
authors.lastname: Bonardo
authors.forename: Eric
authors.initials: E
authors.lastname: Mas
authors.forename: Monique
authors.initials: M
authors.lastname: Aumailley
authors.forename: Irène
authors.initials: I
authors.lastname: Juhan-Vague
authors.forename: Gilles
authors.initials: G
authors.lastname: Nalbone
authors.forename: Franck
authors.initials: F
authors.lastname: Peiretti
mesh_terms: D051722:ADAM Proteins / Q000737:chemistry / Q000378:metabolism*; D000072198:ADAM17 Protein; D000199:Actins / Q000378:metabolism; D000595:Amino Acid Sequence; D000818:Animals; D019556:COS Cells; D002460:Cell Line; D002522:Chlorocebus aethiops; D003599:Cytoskeleton / Q000378:metabolism*; D049452:Green Fluorescent Proteins / Q000378:metabolism; D018398:Homeodomain Proteins / Q000378:metabolism*; D060850:LIM-Homeodomain Proteins; D017737:Macrophages, Peritoneal / Q000187:drug effects / Q000378:metabolism; D008565:Membrane Proteins / Q000378:metabolism; D051379:Mice; D018345:Mice, Knockout; D008969:Molecular Sequence Data; D009124:Muscle Proteins / Q000378:metabolism*; D032383:Myocytes, Cardiac / Q000166:cytology / Q000378:metabolism / Q000648:ultrastructure; D011485:Protein Binding; D051381:Rats; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014157:Transcription Factors / Q000378:metabolism*
chemical_list: D000199:Actins; C491381:Fhl2 protein, rat; D018398:Homeodomain Proteins; D060850:LIM-Homeodomain Proteins; D008565:Membrane Proteins; D009124:Muscle Proteins; D014157:Transcription Factors; D049452:Green Fluorescent Proteins; D051722:ADAM Proteins; D000072198:ADAM17 Protein; C000606463:Adam17 protein, mouse; C000606464:Adam17 protein, rat; D013755:Tetradecanoylphorbol Acetate